Back to Journals » Biologics: Targets and Therapy » Volume 11 » default
Biologics: Targets and Therapy
ISSN: 1177-5491
- View all (502)
- Volume 18, 2024 (6)
- Volume 17, 2023 (17)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Archive: Volume 11, 2017
Anti-angiogenic effects of biotechnological therapies in rheumatic diseases
Cantatore FP, Maruotti N, Corrado A, Ribatti D
Biologics: Targets and Therapy 2017, 11:123-128
Published Date: 14 December 2017
Octreotide long-acting repeatable in the treatment of neuroendocrine tumors: patient selection and perspectives
Yau H, Kinaan M, Quinn SL, Moraitis AG
Biologics: Targets and Therapy 2017, 11:115-122
Published Date: 6 December 2017
Anticholinesterase constituents from the leaves of Spondias mombin L. (Anacardiaceae)
Elufioye TO, Obuotor EM, Agbedahunsi JM, Adesanya SA
Biologics: Targets and Therapy 2017, 11:107-114
Published Date: 2 August 2017
Epigenetic memory of oxidative stress: does nephrilin exert its protective effects via Rac1?
Mascarenhas DD, Herndon DN, Arany I
Biologics: Targets and Therapy 2017, 11:97-106
Published Date: 17 July 2017
Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
Haldar P
Biologics: Targets and Therapy 2017, 11:81-95
Published Date: 27 June 2017
Autophagy regulates the stemness of cervical cancer stem cells
Yang Y, Yu L, Li J, Yuan YH, Wang XL, Yan SR, Li DS, Ding Y
Biologics: Targets and Therapy 2017, 11:71-79
Published Date: 21 June 2017
Paradoxical SAPHO syndrome observed during anti-TNF-α therapy for Crohn's disease
Amano H, Matsuda R, Shibata T, Takahashi D, Suzuki S
Biologics: Targets and Therapy 2017, 11:65-69
Published Date: 22 May 2017
Development of a potent invigorator of immune responses endowed with both preventive and therapeutic properties
Talwar GP, Gupta JC, Mustafa AS, Kar HK, Katoch K, Parida SK, Reddi PP, Ahmed N, Saini V, Gupta S
Biologics: Targets and Therapy 2017, 11:55-63
Published Date: 2 May 2017
CUL4A promotes cell invasion in gastric cancer by activating the NF-κB signaling pathway
Gong Y, Xiang XJ, Feng M, Chen J, Fang Z, Xiong J
Biologics: Targets and Therapy 2017, 11:45-53
Published Date: 12 April 2017
New developments in the treatment of multiple myeloma – clinical utility of daratumumab
McEllistrim C, Krawczyk J, O'Dwyer ME
Biologics: Targets and Therapy 2017, 11:31-43
Published Date: 11 April 2017
Neutralizing activities against seasonal influenza viruses in human intravenous immunoglobulin
Onodera H, Urayama T, Hirota K, Maeda K, Kubota-Koketsu R, Takahashi K, Hagiwara K, Okuno Y, Ikuta K, Yunoki M
Biologics: Targets and Therapy 2017, 11:23-30
Published Date: 10 March 2017
A practical guide about biosimilar data for health care providers treating inflammatory diseases
Markenson J, Alvarez DF, Jacobs I, Kirchhoff C
Biologics: Targets and Therapy 2017, 11:13-21
Published Date: 24 February 2017
Biosimilars and the extrapolation of indications for inflammatory conditions
Tesser JRP, Furst DE, Jacobs I
Biologics: Targets and Therapy 2017, 11:5-11
Published Date: 17 February 2017
Book review: Safety of Biologics Therapy
Robak T
Biologics: Targets and Therapy 2017, 11:1-3
Published Date: 18 January 2017